(UVV) Universal - Overview
Sector: Consumer Defensive | Industry: Tobacco | Exchange: NYSE (USA) | Market Cap: 1.319m USD | Total Return: -0.9% in 12m
Stock
Tobacco, Ingredients, Plant-Based, Agriproducts
Total Rating 39
Risk 82
Buy Signal -0.50
Risk 5d forecast
Volatility24.3%
Rel. Tail Risk-10.2%
Reward TTM
Sharpe Ratio-0.04
Alpha-7.14
Character TTM
Beta0.195
Beta Downside0.800
Drawdowns 3y
Max DD29.70%
CAGR/Max DD0.21
EPS (Earnings per Share)
EPS CAGR: 6.84%
EPS Trend: 24.5%
EPS Trend: 24.5%
Last SUE: -4.00
Qual. Beats: 0
Qual. Beats: 0
Revenue
Rev. CAGR: 7.93%
Rev. Trend: 46.0%
Rev. Trend: 46.0%
Qual. Beats: 0
Description: UVV Universal
Universal Corporation (UVV) is an agriproducts company operating in two segments: Tobacco Operations and Ingredients Operations. The company provides leaf tobacco and plant-based ingredients globally.
The Tobacco Operations segment procures, processes, packs, stores, and ships various types of leaf tobacco for consumer product manufacturers. This segment also offers specialty services like custom blending, testing, and reconstituted leaf tobacco manufacturing. The global tobacco market is influenced by health regulations and evolving consumer preferences.
The Ingredients Operations segment produces specialty plant-based ingredients including fruits, vegetables, herbs, and their derivatives. These products are supplied to consumer-packaged goods manufacturers, retailers, and food, beverage, and flavor companies. The food and beverage ingredient sector is characterized by a high demand for natural and functional ingredients.
Founded in 1886 and headquartered in Richmond, Virginia, Universal Corporation has a long history in agricultural supply. For more detailed financial analysis, consider exploring ValueRays comprehensive reports.
- Global tobacco consumption trends impact leaf demand
- Agricultural commodity prices influence input costs
- Regulatory changes in tobacco industry create uncertainty
- Ingredient segment growth diversifies revenue streams
- Currency fluctuations affect international sales and profits
Piotroski VR‑10 (Strict)
3.0
| Net Income: 85.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.46 > 1.0 |
| NWC/Revenue: 49.18% < 20% (prev 46.30%; Δ 2.88% < -1%) |
| CFO/TA 0.03 > 3% & CFO 100.7m > Net Income 85.3m |
| Net Debt (1.03b) to EBITDA (283.5m): 3.63 < 3 |
| Current Ratio: 2.91 > 1.5 & < 3 |
| Outstanding Shares: last quarter (25.2m) vs 12m ago 1.91% < -2% |
| Gross Margin: 18.17% > 18% (prev 0.19%; Δ 1.80k% > 0.5%) |
| Asset Turnover: 96.12% > 50% (prev 99.19%; Δ -3.07% > 0%) |
| Interest Coverage Ratio: 2.88 > 6 (EBITDA TTM 283.5m / Interest Expense TTM 79.1m) |
Altman Z''
5.96
| A: 0.47 (Total Current Assets 2.18b - Total Current Liabilities 751.4m) / Total Assets 3.02b |
| B: 0.40 (Retained Earnings 1.20b / Total Assets 3.02b) |
| C: 0.08 (EBIT TTM 228.1m / Avg Total Assets 3.03b) |
| D: 0.99 (Book Value of Equity 1.48b / Total Liabilities 1.49b) |
| Altman-Z'' Score: 5.96 = AAA |
Beneish M
-2.98
| DSRI: 1.01 (Receivables 633.9m/650.0m, Revenue 2.91b/3.02b) |
| GMI: 1.06 (GM 18.17% / 19.35%) |
| AQI: 1.02 (AQ_t 0.14 / AQ_t-1 0.14) |
| SGI: 0.97 (Revenue 2.91b / 3.02b) |
| TATA: -0.01 (NI 85.3m - CFO 100.7m) / TA 3.02b) |
| Beneish M-Score: -2.98 (Cap -4..+1) = A |
What is the price of UVV shares?
As of April 03, 2026, the stock is trading at USD 52.70 with a total of 160,888 shares traded.
Over the past week, the price has changed by +0.69%, over one month by -2.15%, over three months by +1.01% and over the past year by -0.85%.
Over the past week, the price has changed by +0.69%, over one month by -2.15%, over three months by +1.01% and over the past year by -0.85%.
Is UVV a buy, sell or hold?
Universal has no consensus analysts rating.
What are the forecasts/targets for the UVV price?
| Wallstreet Target Price | 78 | 48% |
| Analysts Target Price | 78 | 48% |
UVV Fundamental Data Overview
as of 29 March 2026
P/E Trailing = 11.9212 P/E Forward = 11.5607
P/S = 0.4516
P/B = 0.8547
P/EG = 2.8892
Revenue TTM = 2.91b USD
EBIT TTM = 228.1m USD
EBITDA TTM = 283.5m USD
Long Term Debt = 616.6m USD (from longTermDebt, last quarter)
Short Term Debt = 473.5m USD (from shortTermDebt, last quarter)
Debt = 1.11b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.03b USD (from netDebt column, last quarter)
Enterprise Value = 2.35b USD (1.32b + Debt 1.11b - CCE 85.2m)
Interest Coverage Ratio = 2.88 (Ebit TTM 228.1m / Interest Expense TTM 79.1m)
EV/FCF = 44.56x (Enterprise Value 2.35b / FCF TTM 52.7m)
FCF Yield = 2.24% (FCF TTM 52.7m / Enterprise Value 2.35b)
FCF Margin = 1.81% (FCF TTM 52.7m / Revenue TTM 2.91b)
Net Margin = 2.93% (Net Income TTM 85.3m / Revenue TTM 2.91b)
Gross Margin = 18.17% ((Revenue TTM 2.91b - Cost of Revenue TTM 2.38b) / Revenue TTM)
Gross Margin QoQ = 18.42% (prev 18.54%)
Tobins Q-Ratio = 0.78 (Enterprise Value 2.35b / Total Assets 3.02b)
Interest Expense / Debt = 1.65% (Interest Expense 18.4m / Debt 1.11b)
Taxrate = 37.83% (25.3m / 66.9m)
NOPAT = 141.8m (EBIT 228.1m * (1 - 37.83%))
Current Ratio = 2.91 (Total Current Assets 2.18b / Total Current Liabilities 751.4m)
Debt / Equity = 0.75 (Debt 1.11b / totalStockholderEquity, last quarter 1.48b)
Debt / EBITDA = 3.63 (Net Debt 1.03b / EBITDA 283.5m)
Debt / FCF = 19.52 (Net Debt 1.03b / FCF TTM 52.7m)
Total Stockholder Equity = 1.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.81% (Net Income 85.3m / Total Assets 3.02b)
RoE = 5.81% (Net Income TTM 85.3m / Total Stockholder Equity 1.47b)
RoCE = 10.94% (EBIT 228.1m / Capital Employed (Equity 1.47b + L.T.Debt 616.6m))
RoIC = 5.44% (NOPAT 141.8m / Invested Capital 2.60b)
WACC = 4.09% (E(1.32b)/V(2.43b) * Re(6.67%) + D(1.11b)/V(2.43b) * Rd(1.65%) * (1-Tc(0.38)))
Discount Rate = 6.67% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF] Terminal Value 80.82% ; FCFF base≈58.5m ; Y1≈38.4m ; Y5≈17.6m
[DCF] Fair Price = N/A (negative equity: EV 557.3m - Net Debt 1.03b = -471.1m; debt exceeds intrinsic value)
EPS Correlation: 24.53 | EPS CAGR: 6.84% | SUE: -4.0 | # QB: 0
Revenue Correlation: 46.04 | Revenue CAGR: 7.93% | SUE: N/A | # QB: 0
EPS next Year (2027-03-31): EPS=4.61 | Chg7d=+0.000 | Chg30d=+0.350 | Revisions Net=+1 | Growth EPS=-1.9% | Growth Revenue=+1.0%
External Resources